“Nuclear-Targeted Engineering of a Lunasin-Derived Peptide Enhances Antiproliferative Activity and AP-1-Associated Gene Modulation in A549 Lung Cancer Cells”. 2026. Al Mustansiriyah Journal of Pharmaceutical Sciences 26 (3): 331-53. https://doi.org/10.32947/ajps.v26i3.1404.